SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : MultiCell Technologies, Inc.
MCET 0.000010000.0%Jan 16 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Shawn Donahue who wrote (150)4/20/2006 6:05:26 PM
From: EACarl  Read Replies (2) of 237
 
Shawn, RE "a developer of therapeutics for the treatment of degenerative neurological diseases, metabolic and endocrinological disorders, and infectious diseases"

Perhaps you'd like to explain how a company that is
broke for all practical purposes can "develop" anything?????

"Broke" as defined by net working capital.

From the latest "Q" dated February 28, 2006

Working capital $ 518,138

Surely you're not going to quote only cash & equivs and
assume that current liabilities do not have to be paid????

Based on a "Q" of cash burn of about $1 million
that means half a "Q" would = ~$500,000.
Half a "Q" from end of Feb = mid April = now.

Or perhaps you'd like to state that cash will last longer
based on MCET shutting down certain operations or "back burnering" certain programs?

What's your preference?
Or would you like to start name calling or asking how many
shares I own? Try addressing the actual issues, it may be
beneficial to any readers of this thread.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext